Monitoring the efficacy of once-weekly teriparatide. Are bone turnover markers useful in predicting fracture risk?

Panagiotis AnagnostisDivision of Endocrinology, Police Medical Centre of Thessaloniki Sarantaporou 10, Thessaloniki, 54 640Greece;Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Aristotle University of ThessalonikiGreeceCorrespondence[email protected]

Spyridon N. KarrasUnit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Aristotle University of ThessalonikiGreece

Dimitrios G. GoulisUnit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Aristotle University of ThessalonikiGreece

"Monitoring the efficacy of once-weekly teriparatide. Are bone turnover markers useful in predicting fracture risk?." Current Medical Research and Opinion, 30(6), pp. 1177–1178

Transparency

Declaration of funding

This letter was not funded.

Declaration of financial/other relationships

This letter was written independently. The authors did not receive financial or professional help with the preparation of the manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Monitoring the efficacy of once-weekly teriparatide. Are bone turnover markers useful in predicting fracture risk?

Transparency

Declaration of funding

Declaration of financial/other relationships

Information for

Open access

Opportunities

Help and information

Monitoring the efficacy of once-weekly teriparatide. Are bone turnover markers useful in predicting fracture risk?

Transparency

Declaration of funding

Declaration of financial/other relationships

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature